Recent cancer research highlighted specific patient needs, with a growing interest in integrative oncology (IO).
Design:
This is a narrative review concerning the Tuscan Healthcare System, which represents a virtuous example of progressive integration of complementary medicine in conventional cancer care.
Results:
The main steps of the process are described, with a specific focus on the 2021 Diagnostic and Therapeutic Care Pathway on Integrative Oncology.
Conclusions:
Implementing an IO service may contribute to respond to patients' demand for complementary therapies, also providing safety and equity of therapeutic access within public health care systems.
Get full access to this article
View all access options for this article.
References
1.
GrantSJ, HunterJ, SeelyD, et al.Integrative oncology: International perspectives. Integr Cancer Ther, 2019; 18(1):1–11; doi: 10.1177/1534735418823266
2.
RossiE, NoberascoC, PicchiM, et al.Complementary and integrative medicine to reduce adverse effects of anticancer therapy. J Altern Complement Med, 2018; 24(9–10):933–941; doi: 10.1089/acm.2018.0143
3.
BonacchiA, ToccafondiA, MambriniA, et al.Complementary needs behind complementary therapies in cancer patients. Psychooncology, 2015; 24(9):1124–1130; doi: 10.1002/pon.3773
4.
WittCM, BalneavesLG, CardosoMJ, et al.A comprehensive definition for integrative oncology. JNCI Monographs, 2017; 2017(52):7; doi: 10.1093/jncimonographs/lgx012
5.
BonacchiA, FazziL, ToccafondiA, et al.Use and perceived benefits of complementary therapies by cancer patients receiving conventional treatment in Italy. J Pain Sympt Manag, 2014; 47(1):26–34; doi: 10.1016/j.jpainsymman.2013.03.014
6.
Tuscany Region. Decreto N. 4167 del 18/09/2015 DGR418/2015: costituzione gruppo di lavoro “Integrazione delle medicine complementari nella Rete oncologica dell’ ITT” [ENG: Regional Decree 4167/2015 Institution of the “Complementary Medicines Integration within the Oncological Network” Working Group]. Not published. http://www301.regione.toscana.it/bancadati/atti/DettaglioAttiD.xml?codprat=2015AD00000005110 [Last accessed: September 5, 2022].
7.
Tuscany Region. Decreto Regionale N. 11285/2020: Istituzione gruppo di lavoro “Integrazione delle medicine complementari nella Rete oncologica” [ENG: Regional Decree 11285/2020: Instituion of the “Complementary Medicines Integration within the Oncological Network” Working Group]. Available from: http://www301.regione.toscana.it/bancadati/atti/DettaglioAttiD.xml?codprat=2020AD00000012112 [Last accessed: June 1, 2022].
8.
RossiE, VitaA, BaccettiS, et al.Complementary and alternative medicine for cancer patients: Results of the EPAAC survey on integrative oncology centres in Europe. Support Care Cancer, 2015; 23(16):1795–1806; doi: 10.1007/s00520-014-2517-4
9.
BaccettiS, Di StefanoM, RossiE.Complementary Medicine for the Cancer Patient. Development and Opportunities of Integrative Oncology. Felici Publisher: Pisa, Italy; 2015.
10.
ISPRO. Delibera 255/2018: Presa atto progetto internazionale di collaborazione fra l'Azienda USL Toscana Centro, l'Istituto per lo Studio e la Prevenzione e la Rete Oncologica della Toscana e il Memorial Sloan Kettering Cancer Center, New York (USA). Approvazione del Memorandum of Understanding International Collaboration for Integrative Oncology [ENG: Resolution 255/2018: Acknowledgement of an international collaboration project between “Azienda USL Toscana Centro, ” ISPRO and Memorial Sloan Kettering Cancer Center, New York (USA). Approval of the Memorandum of Understanding International Collaboration for Integrative Oncology]. 2018. Available from: https://www.ispro.toscana.it/node/2160 [Last accessed: June 1, 2022].
11.
Tuscany Region. Decreto Regionale N. 975/2020: Bando Ricerca Salute 2018 (DD 15397/2018) Individuazione beneficiari e impegno di spesa [ENG: Regional Decree 975/2020: 2018 Regional Call on Health Research (DD 15397/2018). Recipient identification and Delivered Funding]. 2020. Available from: http://www301.regione.toscana.it/bancadati/atti/Contenuto.xml?id=5242074&nomeFile=Decreto_n.975_del_16-01-2020 [Last accessed: September 5, 2022].
12.
Tuscany Region. Delibera N. 418/2015: Integrazione delle medicine complementari nella Rete oncologica dell'Istituto Toscano Tumori [ENG: Resolution 418/2015: Complementary Medicines Integration within the Tuscan Tumor Institute Oncological Network]. 2015. Available from: http://www301.regione.toscana.it/bancadati/atti/DettaglioAttiG.xml?codprat=2015DG00000000324 [Last accessed: June 1, 2022].
13.
Tuscany Region. Decreto Regionale N. 2986/2021: Rete oncologica regionale. Approvazione percorsi diagnostico terapeutici assistenziali: tumori della mammella e tumori del colon-retto [ENG: Regional Decree 2986/2021: Regional Oncological Network. Approval of Diagnostic and Therapeutic Care Pathways: Breast Cancer and Colon-Rectal Cancer]. 2021. Available from: http://www301.regione.toscana.it/bancadati/atti/DettaglioAttiD.xml?codprat=2021AD00000003508 [Last accessed: September 7, 2022].
14.
Tuscany Region. Decreto Regionale N. 19664/2021: Rete oncologica regionale. Approvazione Percorso diagnostico terapeutico e assistenziale Medicina integrata per i malati oncologici [ENG: Regional Decree 19664/2021: Regional Oncological Network. Approval of the “Integrative Medicine fot Oncological Patients” Diagnostic and Therapeutic Care Pathway]. 2021. Available from: http://www301.regione.toscana.it/bancadati/atti/DettaglioAttiD.xml?codprat=2021AD00000022220 [Last accessed: September 7, 2022].
15.
Abruzzo Region. DGR N. 546/2021: “Rete Senologica PDTA del Tumore della Mammella” [ENG: Essential Assistance Levels Guarantee and D. M., Salute May 18th, 2021, Fulfillment: Approval of the “Senological Network—Breast Cancer Diagnostic and Therapeutic Care Pathway Technical Document]. 2021. Available from: https://www.regione.abruzzo.it/content/dgr-n-546-del-03092021 [Last accessed: September 7, 2022].
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
